undamentalytics Newsletter
Sign in

Twist Bioscience Corp balance sheet

At the end of fiscal 2025, Twist Bioscience Corp had total assets of $642m, total liabilities of $169m and shareholders' equity of $473m. It held $183m in cash against $0 of debt: net cash of $183m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Sept 20172018Sept 20182019Sept 20192020Sept 20202021Sept 20212022Sept 20222023Sept 20232024Sept 20242025Sept 2025LTMJun 2026
Cash and equivalents31814794466379286226183117
Receivables—51226294044355765
Inventory—6712323932242835
Total current assets—96160335546596424347333321
Goodwill—111228686868282
Total assets—116187399702961776614642672
Accounts payable—810515201421117
Deferred revenue (current)————133276
Total current liabilities—1930366391737191120
Short-term debt—33320————
Long-term debt—741——————
Total debt01085200000
Total liabilities—273563121172153142169227
Shareholders' equity−133−201152336581789623473473446
Non-controlling interests and other (assets − liabilities − equity)—290————————
Net debt (negative = net cash)−31−71−39−89−464−379−286−226−183−117
Shares outstanding——33m45m49m57m58m59m61m63m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CSTL vs TWSTTWST vs VCYTFLGT vs TWST

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Twist Bioscience Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Twist Bioscience Corp.